Posted July 26, 2014

Marketers of Nopal Cactus Drink Settle FTC Charges of Deceptive Claims

TriVita Inc., and marketers of the company's "prickly pear" fruit drink Nopalea have agreed to pay $3.5 million in consumer refunds to settle FTC charges they made deceptive claims that the drink treats health problems ranging from skin conditions to joint pain and respiratory problems.

The company's website promoted the drink, which is made from Nopal cactus, as "Inflammation Relief without a Prescription." Infomercials described Nopalea as an "anti-inflammatory wellness drink" and explained how inflammation is linked to diseases such as diabetes and Alzheimer's, and featured testimonials from supposedly satisfied customers, who were actually paid employees.

The settlement also prohibits the company from making any health claims about Nopalea or any other health product without adequate scientific evidence, specifically, randomized, double-blind, placebo-controlled human clinical tests conducted by qualified researchers.

Update (7/31/2014): As a result of this settlement, consumers who purchased Nopalea from the company's website or by phone are eligible for a partial refund (based on the amount provided by the settlement) and will receive more information and/or a refund check via mail, according to information obtained by ConsumerLab.com from the FTC.

See the article on Nopal for more information about this ingredient.

Also see Review Article on Noni Juice and the Review of Acai Berry Supplements and Beverages for information and tests of other popular juice drinks.

See Related Warnings:

FTC Charges Seller of Green Coffee Bean with False Weight Loss Claims, Fake Websites

Four Companies Settle FTC Charges of Deceptive Weight Loss Claims

FTC Stops Fake News Sites About Acai Berry Products

Marketers of "Genetically Customized" Supplements Settle FTC Charges of Deceptive Health Claims

FTC Refunds Consumers of Children's Vitamins as Part of Deceptive Advertising Settlement
To read the FTC's press release, use the link below.